一个刺激响应的聚聚的逆相过渡的Allosteric启动由连接体结合
Bumjoon Kim1, Ashutosh Chilkoti
1Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708-0281, USA.
Journal of the American Chemical Society
|December 6, 2008
概括
我们开发了一种新的生物聚合物执行器,它使用连接物结合来控制聚合物相位过渡. 这项创新使得响应生物信号的智能材料能够用于药物输送和诊断领域的应用.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 分子工程分子工程分子工程
背景情况:
- 响应刺激的聚合物,如弹性类多 (ELPs),表现出可调节的相位过渡.
- 通过特定的生化触发器控制这些相位过渡仍然是一个挑战.
研究的目的:
- 设计一种生物聚合物执行器,将连接接体结合与水性脱混合相过渡.
- 通过生物分子识别来证明弹性样多 (ELP) 低临界溶液温度 (LCST) 阶段过渡的全调节.
主要方法:
- 通过将calmodulin (CaM) 与ELP域融合,构建了一个模块化生物聚合物执行器.
- 研究了与CaM的结合及其对ELP相位过渡行为的影响.
- 评估了CaM-ELP系统的可逆性,选择性和特异性.
主要成果:
- 与CaM结合,全osterically触发了ELP的可逆LCST相变,形成粒子.
- 颗粒的形成取决于ELP链的长度,并且在化时可逆.
- 该系统证明了对的选择性超过的选择性,以及对联体的特异性.
结论:
- 首次证明了聚合物LCST相变的生物分子识别触发的全调节.
- 扩大了对刺激反应性聚合物的触发剂范围,包括生物化学联体结合.
- 这种模块化设计为药物输送,蛋白质组学和纳米尺度设备中的"智能"聚合物执行器提供了潜力.
相关概念视频
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...


